Jazz Pharmaceuticals Net Worth

Jazz Pharmaceuticals Net Worth Analysis

Know Jazz Pharmaceuticals' Top Institutional Investors

Note, although Jazz Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Jazz Pharmaceuticals' market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.42 B.

Project Jazz Pharmaceuticals' profitablity

The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Jazz Pharmaceuticals' management efficiency

Jazz Pharmaceuticals PLC has return on total asset (ROA) of 0.0462 % which means that it generated a profit of $0.0462 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1209 %, meaning that it created $0.1209 on every $100 dollars invested by stockholders. Jazz Pharmaceuticals' management efficiency ratios could be used to measure how well Jazz Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Jazz Pharmaceuticals' Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.04 in 2024, whereas Return On Capital Employed is likely to drop 0.06 in 2024. At this time, Jazz Pharmaceuticals' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 8.4 B in 2024, whereas Other Assets are likely to drop slightly above 136.8 M in 2024.

Jazz Pharmaceuticals Corporate Filings

Jazz Pharmaceuticals time-series forecasting models is one of many Jazz Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jazz Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Jazz Pharmaceuticals Earnings per Share Projection vs Actual

Jazz Pharmaceuticals Corporate Management

Additional Tools for Jazz Stock Analysis